does medicare cover glp-1 for diabetes Recent Trends in Use and Spending in What Is the Medicare GLP-1

It is possible that more pronounced changes in muscle mass or metabolic improvements could be observed with longer treatment periods

Importantly, efpeglenatides immunogenicity remained relatively low, with few patients developing clinically significant anti-drug antibodies, allowing its safety profile to be viewed as manageable within class expectations

In the 24 to 48 hours post-injection when side effects may be elevated, keep your eating window consistent but do not add additional restriction

However, not all individuals experience the same degree of benefit

Pinch the Skin: Gently pinch the skin at the injection site to create a small fold